搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Escherichia coli O81 Rhamnulose-1-phosphate aldolase (rhaD) CSB-YP486227EOP
CSB-EP486227EOP
CSB-BP486227EOP
CSB-MP486227EOP
CSB-EP486227EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Ferrous-iron efflux pump FieF (fieF), partial CSB-YP486228EOP1
CSB-EP486228EOP1
CSB-BP486228EOP1
CSB-MP486228EOP1
CSB-EP486228EOP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 50S ribosomal protein L31 (rpmE) CSB-YP486229EOP
CSB-EP486229EOP
CSB-BP486229EOP
CSB-MP486229EOP
CSB-EP486229EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Thr operon leader peptide (thrL) CSB-YP486230EOP
CSB-EP486230EOP
CSB-BP486230EOP
CSB-MP486230EOP
CSB-EP486230EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Phosphoglycerol transferase I (mdoB), partial CSB-YP486231EOP1
CSB-EP486231EOP1
CSB-BP486231EOP1
CSB-MP486231EOP1
CSB-EP486231EOP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Macrodomain Ter protein (matP) CSB-YP486232EOG
CSB-EP486232EOG
CSB-BP486232EOG
CSB-MP486232EOG
CSB-EP486232EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Curved DNA-binding protein (cbpA) CSB-YP486233EOG
CSB-EP486233EOG
CSB-BP486233EOG
CSB-MP486233EOG
CSB-EP486233EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Probable phosphatase YcdX (ycdX) CSB-YP486234EOG
CSB-EP486234EOG
CSB-BP486234EOG
CSB-MP486234EOG
CSB-EP486234EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 UPF0745 protein YcgL (ycgL) CSB-YP486235EOG
CSB-EP486235EOG
CSB-BP486235EOG
CSB-MP486235EOG
CSB-EP486235EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Peptidyl-tRNA hydrolase (pth) CSB-YP486236EOG
CSB-EP486236EOG
CSB-BP486236EOG
CSB-MP486236EOG
CSB-EP486236EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 UPF0263 protein yciU (yciU) CSB-YP486237EOG
CSB-EP486237EOG
CSB-BP486237EOG
CSB-MP486237EOG
CSB-EP486237EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 GTP cyclohydrolase-2 (ribA) CSB-YP486238EOG
CSB-EP486238EOG
CSB-BP486238EOG
CSB-MP486238EOG
CSB-EP486238EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Trans-aconitate 2-methyltransferase (tam) CSB-YP486239EOG
CSB-EP486239EOG
CSB-BP486239EOG
CSB-MP486239EOG
CSB-EP486239EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Quinate/shikimate dehydrogenase (ydiB) CSB-YP486240EOG
CSB-EP486240EOG
CSB-BP486240EOG
CSB-MP486240EOG
CSB-EP486240EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Phenylalanine--tRNA ligase alpha subunit (pheS) CSB-YP486241EOG
CSB-EP486241EOG
CSB-BP486241EOG
CSB-MP486241EOG
CSB-EP486241EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 N-succinylglutamate 5-semialdehyde dehydrogenase (astD) CSB-YP486242EOG
CSB-EP486242EOG
CSB-BP486242EOG
CSB-MP486242EOG
CSB-EP486242EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 50S ribosomal protein L25 (rplY) CSB-YP486243EOG
CSB-EP486243EOG
CSB-BP486243EOG
CSB-MP486243EOG
CSB-EP486243EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 3-demethylubiquinone-9 3-methyltransferase (ubiG) CSB-YP486244EOG
CSB-EP486244EOG
CSB-BP486244EOG
CSB-MP486244EOG
CSB-EP486244EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Undecaprenyl-phosphate 4-deoxy-4-formamido-L-arabinose transferase (arnC), partial CSB-YP486245EOG1
CSB-EP486245EOG1
CSB-BP486245EOG1
CSB-MP486245EOG1
CSB-EP486245EOG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 o-succinylbenzoate synthase (menC) CSB-YP486246EOG
CSB-EP486246EOG
CSB-BP486246EOG
CSB-MP486246EOG
CSB-EP486246EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>